These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26951201)

  • 1. In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.
    Shen Z; Yeh LT; Wallach K; Zhu N; Kerr B; Gillen M
    Clin Drug Investig; 2016 Jun; 36(6):443-52. PubMed ID: 26951201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.
    Yang C; Zhou D; Shen Z; Wilson DM; Renner M; Miner JN; Girardet JL; Lee CA
    Drug Metab Dispos; 2019 Feb; 47(2):104-113. PubMed ID: 30442650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
    Shen Z; Rowlings C; Kerr B; Hingorani V; Manhard K; Quart B; Yeh LT; Storgard C
    Drug Des Devel Ther; 2015; 9():3423-34. PubMed ID: 26170627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
    Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
    Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
    J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.
    Shen Z; Lee CA; Wallach K; Valdez S; Wilson DM; Kerr B; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):657-663. PubMed ID: 30758919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED
    Drugs Aging; 2017 May; 34(5):401-410. PubMed ID: 28425024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study.
    Alghamdi YS; Soliman MM; Nassan MA
    BMC Pharmacol Toxicol; 2020 Feb; 21(1):10. PubMed ID: 32041665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.
    Gillen M; Yang C; Wilson D; Valdez S; Lee C; Kerr B; Shen Z
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):363-376. PubMed ID: 28067999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.
    Shen Z; Tieu K; Wilson D; Bucci G; Gillen M; Lee C; Kerr B
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):377-387. PubMed ID: 28074640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study.
    Shen Z; Gillen M; Tieu K; Nguyen M; Harmon E; Wilson DM; Kerr B; Lee CA
    Drug Des Devel Ther; 2016; 10():3509-3517. PubMed ID: 27826183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
    Gillen M; Valdez S; Zhou D; Kerr B; Lee CA; Shen Z
    Drug Des Devel Ther; 2016; 10():3555-3562. PubMed ID: 27843295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro.
    Heitel P; Gellrich L; Heering J; Goebel T; Kahnt A; Proschak E; Schubert-Zsilavecz M; Merk D
    Sci Rep; 2018 Sep; 8(1):13554. PubMed ID: 30202096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
    Tausche AK; Alten R; Dalbeth N; Kopicko J; Fung M; Adler S; Bhakta N; Storgard C; Baumgartner S; Saag K
    Rheumatology (Oxford); 2017 Dec; 56(12):2170-2178. PubMed ID: 29029210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a potent and selective inhibitor of human urate transporter 1.
    Wu T; Chen J; Dong S; Li H; Cao Y; Tian Y; Fu W; Zhou P; Xi B; Pang J
    Pharmacol Rep; 2017 Oct; 69(5):1103-1112. PubMed ID: 28988709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study.
    Kandhwal K; Dey S; Nazarudheen S; Arora R; Reyar S; Thudi NR; Monif T; Singh MK; Rao S
    Clin Drug Investig; 2011 Dec; 31(12):853-63. PubMed ID: 21919543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
    Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
    Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesinurad: First Global Approval.
    Hoy SM
    Drugs; 2016 Mar; 76(4):509-16. PubMed ID: 26861027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
    Fleischmann R; Kerr B; Yeh LT; Suster M; Shen Z; Polvent E; Hingorani V; Quart B; Manhard K; Miner JN; Baumgartner S;
    Rheumatology (Oxford); 2014 Dec; 53(12):2167-74. PubMed ID: 24509406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.